Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RLMD
#2648
Relmada Therapeutics, Inc. Common Stock
7.1
8
USD
-0.14%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.14%
Monthly Change
+20.07%
6 month change
+246.86%
Year Change
+2293.33%
Previous Close
7.1
9
Open
7.1
8
Bid
Ask
Low
7.1
8
High
7.1
8
Volume
46
Markets
US Stock Market
Healthcare
RLMD
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
33.19 M
33.19 M
33.19 M
73.33 M
104.89 M
—
Valuation ratios
Enterprise value
13.4 M
7.81 M
18.57 M
146.02 M
503.12 M
675.52 M
Price to earnings ratio
-0.2
-0.11
-0.27
-1.12
-3.33
-4.83
Price to sales ratio
41.84
21.2
61.6
840.01
-2 407.45
-1 484.64
Price to cash flow ratio
-0.3
-0.14
-0.37
-1.57
-4.16
-6.25
Price to book ratio
0.44
0.05
0.15
0.75
2.2
3.15
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.41
-0.63
-0.47
-0.68
-0.21
-1.99
Return on equity %
-0.53
-0.78
-0.62
-1.07
-0.23
-2.7
Return on invested capital %
—
—
—
—
-392.2 K
—
Gross margin %
100
100
100
100
100
400
Operating margin %
-46.7 K
-28.94 K
-21.65 K
12.68 K
18.84 K
-19.07 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
-45.68 K
-27.89 K
-20.9 K
12.39 K
18.41 K
-17.99 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
4.45
5.29
4.11
2.86
14.62
26.87
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
-0
-0
-0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.29
-0.59
-0.19
-0.2
-0.37
-1.36
EBIT per share
-0.63
-0.6
-0.31
-0.31
-0.52
-1.73
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.49
0.89
0.62
0.42
2.36
4.29
Net current asset value per share
1.52
0.91
0.64
0.45
2.38
4.37
Tangible book value per share
1.18
0.74
0.48
0.29
2.19
3.69
Working capital per share
1.18
0.74
0.48
0.29
2.22
3.73
Book value per share
1.18
0.74
0.48
0.29
2.19
3.69
News
Does Relmada Therapeutics (RLMD) Have the Potential to Rally 75.58% as Wall Street Analysts Expect?
Relmada Therapeutics: 2 New Assets, 2 New 'Blockbusters'? I'd Wait And See (NASDAQ:RLMD)
Relmada Therapeutics, Inc. (RLMD) Q4 2025 Earnings Call Transcript
Mizuho reiterates Relmada stock rating on positive cancer trial data
RLMD Stock Surges 42% in a Week: Here's What You Should Know
Avago, Lumentum among market cap stock movers on Monday
Tesla and Facebook among market cap stock movers on Monday
Mizuho reiterates Relmada stock rating on bladder cancer trial data
Hims & Hers shares soar premarket; Pfizer, Agilent Technologies slip
Relmada Therapeutics stock surges 25% on bladder cancer data
Relmada reports 76% response rate for bladder cancer therapy
Relmada Therapeutics secures $160M in PIPE financing